Navigation Links
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Date:11/4/2009

SAN CARLOS, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2009.

Net loss for the quarter ended September 30, 2009 improved to $31.0 million or $0.33 per share, as compared to a net loss of $37.0 million or $0.40 per share in the third quarter of 2008.

Nektar continued to make improvements to its operating efficiencies as compared to a year ago. Total operating costs and expenses were down 30% to $39.1 million in the third quarter of 2009 as compared to $56.0 million in the third quarter of 2008. For the first nine months of 2009, total operating costs and expenses were down 29% to $122.6 million as compared to $171.6 million in the first nine months of 2008.

"We are extremely pleased with our success in the third quarter," said Howard W. Robin, President and Chief Executive Officer of Nektar. "We signed a landmark collaboration with AstraZeneca for NKTR-118 and NKTR-119 that highlights the compelling value we are creating in our clinical pipeline. We are also making great progress with NKTR-102, with enrollment in our Phase 2 ovarian cancer study completed ahead of schedule. Our clinical results continue to validate the potential of Nektar's proprietary advanced polymer conjugate technology in creating important new therapeutics."

Research and development expense was $23.5 million in the third quarter of 2009 as compared to $38.3 million for the same quarter in 2008. For the first nine months of 2009, research and development expense was $71.5 million as compared to $109.1 million in the same period in 2008. Included in the $71.5 million of overall research and development expenses in the first nine months of 2009 is approximately $40.0 million of investment in Nektar preclinical and clin
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Host Conference Call to Discuss Todays Announcement of a New Partnership for NKTR-118 and NKTR-119
3. AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
4. Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
5. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
7. Nektar Therapeutics Reports First Quarter 2009 Financial Results
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
9. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
10. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
11. Nektar Announces Retirement of Irwin Lerner from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 2013 Z Trim Holdings, Inc. (OTC Markets: ... variety of industries, announced that Chef Erin ... this year,s National Restaurant Association ("NRA") NRA Show, which ... the Research Chefs Association.  Chef Ryan spoke on the ... Bad and the Ugly," joining four other prestigious panelists ...
(Date:5/23/2013)... Canada (PRWEB) May 23, 2013 ... it is critical to adhere to principles of ... (HSP). , Esteemed speaker Dr. Jeremy Lim, Fellow, ... audience: , ,     Understand the International ... Practice (GCP) and additional regulations for the conduction ...
(Date:5/23/2013)... May 23, 2013 Bed bugs ... university had already confirmed it. Meanwhile, My Cleaning Products offered ... bug victims fight the pests without using harmful chemical elements. ... May 15, 2013, the affected building was actually a ... infested was said made on May 13 and bed bug ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... isn,t your father,s nanocar. It runs cool. , The drivers ... of their creation have the ability to roll at room ... years away, the breakthrough suggests they,ll be easier to adapt ... had to be heated to 200 degrees Celsius before they ...
... The American Institute of Aeronautics and Astronautics has published ... that compiles for the first time the emerging science ... drives, gravity control, and faster-than-light travel breakthroughs that would ... systems. , While the subject matter may sound ...
... deCODE genetics,(Nasdaq: DCGN ) announced that on February ... Qualifications Panel (the "Panel") stating that the Panel,will transfer ... Global,Market to the Nasdaq Capital Market, effective at the ... The Nasdaq Capital Market, which is,one of the three ...
Cached Biology Technology:Rice rolls out new nanocars 2Rice rolls out new nanocars 3New book from AIAA explores space drives, warp drives 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 3
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
(Date:5/22/2013)... cellular DNA can endanger the whole organism, as they ... Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts of ... , The DNA in our cells controls the form ... The instructions for this are encoded in the linear ... bases adenine (A), cytosine (C), guanine (G) and thymine ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2DNA damage: The dark side of respiration 2
... ever lower amounts of ionising radiation with ever better ... start of the nuclear age. In addition to natural ... sources of radiation which result from the military and ... also for technical and medical applications, it is necessary ...
... 2008 Researchers at UT Southwestern Medical Center ... of nerves by outfitting electrodes with the latest ... black, formed from carbon nanotubes. The nanotube ... electrodes, which researchers say is a potentially critical ...
... CORVALLIS, Ore. More than 125 years ago Charles Darwin ... the night, not the day and this week, scientists ... phenomenon. These rhythmic growth spurts, and the ability of ... by genes involved in circadian rhythms the "biological clock" ...
Cached Biology News:Radioactivity: Discover the lowest amounts with new methods 2Radioactivity: Discover the lowest amounts with new methods 3Coating improves electrical stimulation therapy used for Parkinson's, depression, chronic pain 2'Biological clock' genes control plant growth 2
... PBL's bioassays for interferons are cytopathic effect ... assays. Sample types include; tissue culture supernatents; ... In these assays, one unit is defined as ... reduce the cytopathic effect of viral infection by ...
...
... Ultrasonic Nebulizers are available in two product models ... these two models is that the 6000AT+ includes ... a drier aerosol for improved detection limits and ... for a range of elements by 10-40 times. ...
... Cetac Ultrasonic Nebulizers are available in two product ... between these two models is that the 6000AT+ ... create a drier aerosol for improved detection limits ... limits for a range of elements by 10-40 ...
Biology Products: